Dambkowski Carl's Form 4 filing
Apogee Therapeutics, Inc. (APGE) · filed Nov 7, 2025
- Accession no.
- 0001104659-25-108652
- Filed
- Nov 7, 2025
- Trade date
- Nov 5, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $593.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dambkowski CarlCIK 0001983476 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | Common Stock | MOption exerciseAcquired | +8,060 | $22.86 | +$184,251.6 | 292,793 | Direct | |
| Nov 5, 2025 | Common Stock | SSaleDisposed | −2,300 | $53.62 | −$123,326 | 290,493 | Direct | |
| Nov 5, 2025 | Common Stock | SSaleDisposed | −2,200 | $54.83 | −$120,626 | 288,293 | Direct | |
| Nov 5, 2025 | Common Stock | SSaleDisposed | −5,607 | $55.58 | −$311,637.06 | 282,686 | Direct | |
| Nov 5, 2025 | Common Stock | SSaleDisposed | −678 | $56.51 | −$38,313.78 | 282,008 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | Common Stock | MOption exerciseDisposed | −8,060 | $0.00 | $0 | 153,565 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.